MedPath

Micafungin

These highlights do not include all the information needed to use MICAFUNGIN FOR INJECTION safely and effectively. See full prescribing information for MICAFUNGIN FOR INJECTION. MICAFUNGIN for Injection, for intravenous infusion only Initial U.S. Approval: 2005

Approved
Approval ID

b7217896-fb88-44de-afe4-5b1cfef3d4fc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 28, 2022

Manufacturers
FDA

Civica, Inc.

DUNS: 081373942

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Micafungin sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72572-427
Application NumberANDA211713
Product Classification
M
Marketing Category
C73584
G
Generic Name
Micafungin sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 28, 2022
FDA Product Classification

INGREDIENTS (1)

MICAFUNGIN SODIUMActive
Quantity: 100 mg in 1 1
Code: IS1UP79R56
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Micafungin - FDA Drug Approval Details